ERCC2 and gastric cancer: Thus, with a series of new studies published, we conducted a meta-analysis to derive a more precise and comprehensive assessment of the relationship of ERCC2 rs13181 and rs1799793 polymorphisms with the efficacy and clinical outcomes of gastric cancer patients treated with platinum-based chemotherapy.